Autonomous Robot Performs COVID-19 Nasal Swab Tests 
|
By HospiMedica International staff writers Posted on 11 Aug 2020 |
|
The NSR autonomously takes nasal samples (Photo courtesy of Brain Navi Biotechnology)
A new robotic system performs nasal swab tests on its own, helping to prevent cross infections among people being examined.
The Brain Navi Biotechnology (Hsinchu, Taiwan) Nasal Swab Robot (NSR) is designed to automatically, independently, recognize a patient's facial structure and identify the nostril's location, and subsequently take a sample of nasal secretions. The target population are suspected cases of whooping cough, diphtheria, influenza, and other types of diseases caused by the coronavirus family of viruses, including SARS, MERS, and COVID-19. The NSR is equipped with a compact robotic arm and display screen mounted on a wheeled trolley.
The procedure is based on three-dimensional imaging to identify facial and nasal characteristics, without the use of external frames, in order to move through nostrils, twirl the swab to collect a nasopharyngeal swab sample, remove it, and place it in a vial. With the aid of NSR, suspect patients can be tested safely around the clock, sparing medical health care workers the need to done personal protective equipment (PPE) and enter the high-risk environment during sample collecting. NSR could also allow autonomous specimen collection in airports, borders, drive-ins, or medical institutions.
“The SARS outbreak 17 years ago was a profound experience, but also left me deep wounds after losing a dear friend while we were saving lives. So, I decided to develop a robot to help save lives and be the first human to test NSR,” said Jerry Chen, MD, CEO of Brain Navi Biotechnology. “We feel the suffering of thousands of colleagues and patients worldwide with the pandemic. So, we developed the NSR in just eight weeks. We took some essential functions of our Autopilot Brain Surgical Navigation Robot.”
Testing for COVID-19 involves inserting a 15 centimeter long swab into the nasopharyngeal space, a cavity between the nose and mouth for 15 seconds, and rotating it several times. The swabbing is then repeated on the other side of the nose to make sure enough material is collected. The swab is then inserted into a container and sent to a lab for testing.
Related Links:
Brain Navi Biotechnology
The Brain Navi Biotechnology (Hsinchu, Taiwan) Nasal Swab Robot (NSR) is designed to automatically, independently, recognize a patient's facial structure and identify the nostril's location, and subsequently take a sample of nasal secretions. The target population are suspected cases of whooping cough, diphtheria, influenza, and other types of diseases caused by the coronavirus family of viruses, including SARS, MERS, and COVID-19. The NSR is equipped with a compact robotic arm and display screen mounted on a wheeled trolley.
The procedure is based on three-dimensional imaging to identify facial and nasal characteristics, without the use of external frames, in order to move through nostrils, twirl the swab to collect a nasopharyngeal swab sample, remove it, and place it in a vial. With the aid of NSR, suspect patients can be tested safely around the clock, sparing medical health care workers the need to done personal protective equipment (PPE) and enter the high-risk environment during sample collecting. NSR could also allow autonomous specimen collection in airports, borders, drive-ins, or medical institutions.
“The SARS outbreak 17 years ago was a profound experience, but also left me deep wounds after losing a dear friend while we were saving lives. So, I decided to develop a robot to help save lives and be the first human to test NSR,” said Jerry Chen, MD, CEO of Brain Navi Biotechnology. “We feel the suffering of thousands of colleagues and patients worldwide with the pandemic. So, we developed the NSR in just eight weeks. We took some essential functions of our Autopilot Brain Surgical Navigation Robot.”
Testing for COVID-19 involves inserting a 15 centimeter long swab into the nasopharyngeal space, a cavity between the nose and mouth for 15 seconds, and rotating it several times. The swabbing is then repeated on the other side of the nose to make sure enough material is collected. The swab is then inserted into a container and sent to a lab for testing.
Related Links:
Brain Navi Biotechnology
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
12-Channel ECG
CM1200B
New
Patient Monitor
Vista 300
New
Mattress Replacement System
Apollo Infant Dynamic
Latest Health IT News
- Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
- Smartwatches Could Detect Congestive Heart Failure
- Versatile Smart Patch Combines Health Monitoring and Drug Delivery
- Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients
- Strategic Collaboration to Develop and Integrate Generative AI into Healthcare
- AI-Enabled Operating Rooms Solution Helps Hospitals Maximize Utilization and Unlock Capacity
- AI Predicts Pancreatic Cancer Three Years before Diagnosis from Patients’ Medical Records
- First Fully Autonomous Generative AI Personalized Medical Authorizations System Reduces Care Delay
- Electronic Health Records May Be Key to Improving Patient Care, Study Finds
- AI Trained for Specific Vocal Biomarkers Could Accurately Predict Coronary Artery Disease
Channels
Critical Care
view channel
Ingestible Smart Capsule for Chemical Sensing in the Gut Moves Closer to Market
Intestinal gases are associated with several health conditions, including colon cancer, irritable bowel syndrome, and inflammatory bowel disease, and they have the potential to serve as crucial biomarkers... Read more
Novel Cannula Delivery System Enables Targeted Delivery of Imaging Agents and Drugs
Multiphoton microscopy has become an invaluable tool in neuroscience, allowing researchers to observe brain activity in real time with high-resolution imaging. A crucial aspect of many multiphoton microscopy... Read more
Novel Intrabronchial Method Delivers Cell Therapies in Critically Ill Patients on External Lung Support
Until now, administering cell therapies to patients on extracorporeal membrane oxygenation (ECMO)—a life-support system typically used for severe lung failure—has been nearly impossible.... Read more
Surgical Techniques
view channel
Pioneering Sutureless Coronary Bypass Technology to Eliminate Open-Chest Procedures
In patients with coronary artery disease, certain blood vessels may be narrowed or blocked, requiring a stent or a bypass (also known as diversion) to restore blood flow to the heart. Bypass surgeries... Read more
Intravascular Imaging for Guiding Stent Implantation Ensures Safer Stenting Procedures
Patients diagnosed with coronary artery disease, which is caused by plaque accumulation within the arteries leading to chest pain, shortness of breath, and potential heart attacks, frequently undergo percutaneous... Read more
World's First AI Surgical Guidance Platform Allows Surgeons to Measure Success in Real-Time
Surgeons have always faced challenges in measuring their progress toward surgical goals during procedures. Traditionally, obtaining measurements required stepping out of the sterile environment to perform... Read more
Patient Care
view channel
Portable Biosensor Platform to Reduce Hospital-Acquired Infections
Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds
Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more
Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization
An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more
Game-Changing Innovation in Surgical Instrument Sterilization Significantly Improves OR Throughput
A groundbreaking innovation enables hospitals to significantly improve instrument processing time and throughput in operating rooms (ORs) and sterile processing departments. Turbett Surgical, Inc.... Read moreBusiness
view channel
Expanded Collaboration to Transform OR Technology Through AI and Automation
The expansion of an existing collaboration between three leading companies aims to develop artificial intelligence (AI)-driven solutions for smart operating rooms with sophisticated monitoring and automation.... Read more
